Up | AC
Home Page
Food and
Drug Administration
Risk Communication Advisory Committee
May 15 and 16, 2008
BRIEFING INFORMATION
FDA
Disclaimer
Portions of this document have been determined to be exempt
from disclosure under the Freedom of Information Act (the
FOIA) (5 U.S.C. §552). These redacted portions will appear
as white space on the screen or on the printed page.
Statutory Language (pdf)
Comments Related to Required Report on Direct-to-Consumer Advertising
[Docket No. FDA-2008-N-0226] (pdf)
Excerpt from Draft Scientific Literature on Direct-to-Consumer Advertising of Prescription Pharmaceuticals, 2004-2008, prepared for the FDA by Eastern Research Group (pdf)
Medicines in My Home: RCAC Backgrounder (pdf)
Medicines in My Home: Student Version (pdf)
Medicines in My Home: Booklet-Student-Web (pdf)
Medicines in My Home: Project (pdf)
Medicines in My Home: Feel Better (pdf)
Medicines in My Home: All-About-Me (pdf)
Trial backgrounder (
pdf)